Next Article in Journal
A Framework for the Organization and Delivery of Systemic Treatment
Previous Article in Journal
The Role of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Therapy for Advanced, Metastatic, and Recurrent Non-Small-Cell Lung Cancer: A Canadian National Consensus Statement
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

In This Issue of Current Oncology

by
Current Oncology Editorial Office
Multimed Inc., Milton, ON L9T 2R2, Canada
Curr. Oncol. 2009, 16(1), 3; https://doi.org/10.3747/co.v16i6.573
Submission received: 3 October 2008 / Revised: 7 November 2008 / Accepted: 10 December 2008 / Published: 1 January 2009

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

In this editorial for the first issue of Current Oncology’s sixteenth year, I am pleased to begin with the important announcement that Dr. Martin Chasen has graciously accepted the position of managing editor [...]

Share and Cite

MDPI and ACS Style

, Current Oncology Editorial Office. In This Issue of Current Oncology. Curr. Oncol. 2009, 16, 3. https://doi.org/10.3747/co.v16i6.573

AMA Style

Current Oncology Editorial Office. In This Issue of Current Oncology. Current Oncology. 2009; 16(1):3. https://doi.org/10.3747/co.v16i6.573

Chicago/Turabian Style

Current Oncology Editorial Office. 2009. "In This Issue of Current Oncology" Current Oncology 16, no. 1: 3. https://doi.org/10.3747/co.v16i6.573

APA Style

, Current Oncology Editorial Office. (2009). In This Issue of Current Oncology. Current Oncology, 16(1), 3. https://doi.org/10.3747/co.v16i6.573

Article Metrics

Back to TopTop